Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Clinical trial NCT05712889 · COMPLETED
Trial details
- NCT number
- NCT05712889
- Sponsor
- Vincerx Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-24
- Primary completion
- 2024-10-10
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.